Patents Assigned to The Kennedy Trust for Rheumatology Research
  • METHODS FOR REDUCING POST-OPERATIVE COGNITIVE DYSFUNCTION (POCD)
    Publication number: 20220112281
    Abstract: The present invention provides method, uses and agents for preventing or reducing cognitive decline in a patient following a planned inflammatory trigger. Such planned inflammatory trigger can be a surgical procedure or chemotherapy. The invention further provides methods, uses and agents for reducing cognitive decline in a patient with a cognitive disorder, wherein said patient has been exposed to an inflammatory trigger. Pharmaceutical compositions and kits are also provided.
    Type: Application
    Filed: December 20, 2021
    Publication date: April 14, 2022
    Applicant: The Kennedy Trust for Rheumatology Research
    Inventors: Mervyn Maze, Marc Feldmann, Noccolo Terrando, Mario Cibelli, Daqing Ma, Michael Fertleman, Jagdeep Nanchahal
  • Methods for reducing post-operative cognitive dysfunction (POCD)
    Patent number: 11220540
    Abstract: The present invention provides method, uses and agents for preventing or reducing cognitive decline in a patient following a planned inflammatory trigger. Such planned inflammatory trigger can be a surgical procedure or chemotherapy. The invention further provides methods, uses and agents for reducing cognitive decline in a patient with a cognitive disorder, wherein said patient has been exposed to an inflammatory trigger. Pharmaceutical compositions and kits are also provided.
    Type: Grant
    Filed: October 23, 2019
    Date of Patent: January 11, 2022
    Assignee: THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH
    Inventors: Mervyn Maze, Marc Feldmann, Noccolo Terrando, Mario Cibelli, Daqing Ma, Michael Fertleman, Jagdeep Nanchahal
  • METHOD FOR PREVENTING OR REDUCING POST-OPERATIVE COGNITIVE DYSFUNCTION (POCD)
    Publication number: 20200123245
    Abstract: The present invention provides method, uses and agents for preventing or reducing cognitive decline in a patient following a planned inflammatory trigger. Such planned inflammatory trigger can be a surgical procedure or chemotherapy. The invention further provides methods, uses and agents for reducing cognitive decline in a patient with a cognitive disorder, wherein said patient has been exposed to an inflammatory trigger. Pharmaceutical compositions and kits are also provided.
    Type: Application
    Filed: October 23, 2019
    Publication date: April 23, 2020
    Applicant: The Kennedy Trust for Rheumatology Research
    Inventors: Mervyn Maze, Marc Feldmann, Noccolo Terrando, Mario Cibelli, Daqing Ma, Michael Fertleman